Banco Bilbao Vizcaya Argentaria »

Alnylam Pharmaceuticals shares owned by Banco Bilbao Vizcaya Argentaria

Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by Banco Bilbao Vizcaya Argentaria from 13F filings

Historical chart of Banco Bilbao Vizcaya Argentaria investment in Alnylam Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals held by Banco Bilbao Vizcaya Argentaria consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals by Banco Bilbao Vizcaya Argentaria

Quarter filed Position value Share count Share price at filing
2024-09-30 $6.0M 22k 275.03

More positions owned by Banco Bilbao Vizcaya Argentaria

Microsoft Corp Common Stock (MSFT)
Apple Common Stock
NVIDIA Corp Common Stock (NVDA)
Amazon.com Common Stock
SPDR S&P 500 ETF Trust Etp (SPY)
Facebook Common Stock (META)
Alphabet Common Stock (GOOGL)
Alphabet Common Stock (GOOG)
iShares Short Treasury Bond ETF Etp (SHV)
SPDR Bloomberg Barclays 1-3 Month T-Bill ETF Etp (BIL)
Financial Select Sector SPDR Fund Etp (XLF)
Coinbase Global Common Stock (COIN)
iShares 20 Year Treasury Bond ETF Etp (TLT)
Invesco QQQ Trust Series 1 Etp (QQQ)
Vanguard Short-Term Corporate Bond ETF Etp (VCSH)

View all positions for Banco Bilbao Vizcaya Argentaria

Top funds holding Alnylam Pharmaceuticals

Capital World Investors
Vanguard Group
BlackRock
BlackRock
Capital Research Global Investors
Baillie Gifford & Co
Capital Research and Management Company - Division 3
Dodge & Cox
State Street Corporation
T. Rowe Price Associates
T. Rowe Price Investment Management
Jpmorgan Chase & Co
Geode Capital Management
American Century Companies
Groupama Asset Managment

View all funds holding Alnylam Pharmaceuticals